Entero Healthcare IPO Details ( Entero Healthcare Solutions Limited IPO Review )
(9 Feb 2024 – 13 Feb 2024)
Established in 2018, Entero Healthcare Solutions Limited operates as a healthcare product distributor in India. Using advanced technology, the company delivers healthcare products to pharmacies, hospitals, and clinics across the country.
Throughout the fiscal years 2021, 2022, and 2023, Entero Healthcare Solutions catered to 39,500, 64,200, and 81,400 retail customers, respectively. In the same period, they also served 1,600, 2,500, and 3,400 hospital customers.
Entero Healthcare Solutions collaborates with more than 1,900 healthcare product manufacturers, granting them access to a diverse range of over 64,500 product variations as of March 31, 2023.
With 73 warehouses spread across 37 cities in 19 states and union territories, the company’s extensive reach encompasses 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This widespread network ensures efficient connections with healthcare product manufacturers.
As of March 31, 2023, Entero Healthcare Solutions employs a total of 3,014 individuals across various departments.
Entero Healthcare Solutions Limited IPO Competitive Strength
- We operate in the large and highly fragmented Indian healthcare products distribution market and expect to benefit from market consolidation
- We are one of India’s largest and fastest growing healthcare products distribution platforms
- Track record of inorganic expansion and integration to grow our geographic reach, revenues and scale
- Differentiated business model offering comprehensive and integrated commercial and supply chain solutions
- Proprietary technology platform with integrated business intelligence tools and solutions
- Experienced, committed and qualified founding and professional management team with deep industry expertise and backed by healthcare focused investor
Entero Healthcare IPO Financials Performance ( Results )
Entero Healthcare Solutions Limited Financial Information (Restated Consolidated)
All Amount in ₹ Lakhs
Period Ended | Total Assets | Total Revenue | PAT | EPS (₹) | Net Worth | Borrowing |
31-Mar-21 | 833.79 | 1,783.67 | -15.35 | -5.29 | 487.06 | 141.70 |
31-Mar-22 | 1,125.98 | 2,526.55 | -29.44 | -9.22 | 563.22 | 285.03 |
31-Mar-23 | 1,308.73 | 3,305.72 | -11.10 | -3.10 | 597.66 | 373.52 |
30-Sep-23 | 1,505.95 | 1,898.98 | 11.64 | 2.95 | 660.54 | 488.68 |
Objective of Entero Healthcare IPO Issue
- Repayment/prepayment, in full or part, of certain borrowings availed of by the company and its Subsidiaries.
- Funding the long term working capital requirements.
- Pursuing inorganic growth initiatives through acquisitions.
- General corporate purposes.
Entero Healthcare IPO Basic Details
IPO Date | Feb 9, 2024 to Feb 13, 2024 |
Listing Date | Friday, February 16, 2024 |
Face Value | ₹10 per share |
Price | ₹1195 to ₹1258 per share |
Lot Size | 11 Shares |
Issue Size | 12,718,600 shares of ₹10 (aggregating up to ₹1,600.00 Cr) |
Fresh Issue | 7,949,125 shares of ₹10 (aggregating up to ₹1,000.00 Cr) |
Offer for Sale | 4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr) |
Employee Discount | Rs 119 per share |
Issue Type | Book Built Issue IPO |
Listing At | NSE, BSE |
Share holding pre issue | 39,577,705 |
Share holding post issue | 47,526,830 |
Company Promoters | Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited |
Entero Healthcare Solutions IPO Reservation
Anchor Investor Shares Offered | 42.63% of the Net Issue |
QIB Shares Offered | 28.42% of the Net Issue |
NII (HNI) Shares Offered | 14.21% of the Net Issue |
Retail Shares Offered | 14.21% of the Net Issue |
Employee Shares Offered | 0.53% of the Net Issue |
Total Shares Offered | 100% of the Net Issue |
Entero IPO Timetable
Entero IPO will open on February 9, 2024 and close on February 13, 2024. You can join Entero IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.
Event | Date |
Opening Date | 9 February 2024 (Friday) |
Closing Date | 13 February 2024 (Tuesday) |
Basis of Allotment | 14 February 2024 (Wednesday) |
Initiation of Refunds | 15 February 2024 (Thursday) |
Credit of Shares to Demat | 15 February 2024 (Thursday) |
Listing Date | 16 February 2024 (Friday) |
Deadline for UPI mandate confirmation | 5 PM on 13 February 2024 |
Entero Healthcare Solutions IPO Lot Size
For retail investors in Entero Healthcare Solutions IPO, 11 shares will come in 1 lot or the minimum investment will be ₹13,838. Retail-individual investors can apply for up to 14 lots or the maximum investment will be ₹193,732.
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 11 | ₹13,838 |
Retail (Max) | 14 | 154 | ₹193,732 |
S-HNI (Min) | 15 | 165 | ₹207,570 |
S-HNI (Max) | 72 | 792 | ₹996,336 |
B-HNI (Min) | 73 | 803 | ₹1,010,174 |
Entero Healthcare IPO Promoter Holding
The company’s promoters include Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited.
Pre Issue Share Holding | 77.11% |
Post Issue Share Holding |
Entero Healthcare Solutions Ltd IPO Key Performance Indicator ( Valuation )
In the table given below, all the figures have been told according to the latest financial year.
KPI | Values |
Market Cap (₹ Cr.) | 3021.21 |
Earning Per Share (EPS) | ₹-3.10 per Equity Share |
Net Asset Value (NAV) | ₹157.08 per Equity Share |
Post P/E Ratio (P/E) (x) | 129.75 |
Return on Net Worth (RoNW) (%) | -1.86 |
Return on equity (ROE) (%) | -2.66 |
Return on Capital Employed (ROCE) (%) | 6.06 |
Debt/Equity Ratio | 0.45 |
Price/Book Value Ratio | 7.22 |
Entero Healthcare IPO GMP Live Update, Kostak Rate day by day
Date | GMP | Kostak | Subject to |
Today | ₹5 | – | – |
10 February 2024 | ₹5 | – | – |
9 February 2024 | ₹10 | – | – |
8 February 2024 | ₹18 | – | – |
Entero Healthcare IPO Detail Video:
Entero Healthcare IPO Subscription Status (Bidding Detail)
The Entero Healthcare IPO on February 13, 2024 at 7:30:00 PM was subscribed 1.53 times, with the retail category being subscribed 1.33 times, the NII (Non-Institutional Investor) category being subscribed 0.22 times, QIB (Qualified-Institutional Buyers) category being subscribed 2.28 times and the Employee category being subscribed 1.25 times.
Category | Subscription |
QIB | 2.28x |
NII | 0.22x |
Retail | 1.33x |
Employee | 1.25x |
Total | 1.53x |
Entero Healthcare IPO Prospectus
Entero Healthcare IPO DRHP | Download |
Entero Healthcare IPO RHP | Download |
Entero Healthcare IPO Anchor Investors Details PDF | Download |
Entero Healthcare IPO Rating
Our Rating | 1.5/5.0 |
Entero Healthcare Company Contact Information
Entero Healthcare Solutions Limited
Registered Office: Plot No. I-35, Building – B, Industrial Area Phase – I, 13/7 Mathura Road, Faridabad 121 003, Haryana, India
Tel: 0129-4877300
Corporate Office: 605 & 606, 6th Floor, Trade Centre Bandra Kurla Complex, Bandra East, Mumbai 400 051 Maharashtra, India
Tel: +91 22 69019100
Contact Person: Jayant Prakash, Vice President – General Counsel, Company Secretary and Compliance Officer
E-mail: jayant.prakash@enterohealthcare.com
Website: www.enterohealthcare.com
Corporate Identity Number: U74999HR2018PLC072204
Promoters of Our Company: Prabhat Agrawal, Prem Sethi, and Orbimed Asia Iii Mauritius Limited
Entero Healthcare IPO Registrar
Link Intime India Private Limited
Registered Office: C-101, 1st floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai 400 083, Maharashtra, India
Tel: +91 8108114949
E-mail: enterohealthcare.ipo@linkintime.co.in
Investor grievance e-mail: enterohealthcare.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058
Entero Healthcare IPO Lead Manager
ICICI Securities Limited
Registered Office: ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai – 400 025
Tel: +91 22 6807 7100
Email: entero.ipo@icicisecurities.com
Investor grievance email: customercare@icicisecurities.com
Website: www.icicisecurities.com
Contact person: Shekher Asnani / Gaurav Mittal
SEBI registration no: INM000011179
Dam Capital Advisors Limited
Registered Office: One BKC, Tower C, 15th Floor, Unit No. 1511, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051, Maharashtra, India
Tel: +91 22 4202 2500
E-mail: entero.ipo@damcapital.in
Investor grievance e-mail: complaint@damcapital.in
Website: www.damcapital.in
Contact Person: Arpi Chheda
SEBI Registration: MB/INM000011336
Jefferies India Private Limited
Registered Office: 16th Floor, Express Towers, Nariman Point, Mumbai 400 021, Maharashtra, India
Tel: +91 22 4356 6000
E-mail: Enterohealthcare.IPO@jefferies.com
Investor grievance e-mail: jipl.grievance@jefferies.com
Website: www. jefferies.com
Contact Person: Suhani Bhareja
SEBI Registration: INM000011443
JM Financial Limited
Registered Office: 7th Floor, Cnergy Appasaheb Marathe Marg Prabhadevi, Mumbai 400 025, Maharashtra, India
Tel: +91 22 6630 3030
E-mail: entero.ipo@jmfl.com
Investor Grievance E-Mail: grievance.ibd@jmfl.com
Website: www.jmfl.com
Contact person: Prachee Dhuri
SEBI Registration No.: INM000010361
SBI Capital Markets Limited
Registered Office: Unit No. 1501, 15th floor, A & B Wing, Parinee Crescenzo Building, Plot C- 38, G Block, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051, Maharashtra.
Tel: +91 22 4006 9807
E-mail: entero.ipo@sbicaps.com
Investor Grievance E-Mail: investor.relations@sbicaps.com
Website: www.sbicaps.com
Contact person: Aditya Deshpande
SEBI Registration No.: INM000003531
Entero Healthcare IPO FAQs
What is the lot size of Entero Healthcare IPO?
The total size of Entero Healthcare IPO is ₹1,600.00 crores out of which ₹1,000.00 crores is fresh issue and ₹600.00 crores is offer for sale (OFS).
When will Entero Healthcare IPO start?
Entero Healthcare IPO will open from 9 February 2024 and IPO will close on 13 February 2024.
What is the open date of Entero Healthcare IPO?
Entero Healthcare IPO will open date from 9 February 2024.
What is the last date ( close date ) of Entero Healthcare IPO?
Entero Healthcare IPO will close from 13 February 2024.
What is the price band of Entero Healthcare IPO?
Entero Healthcare IPO price band is ₹1195 to ₹1258. ( Upper Price Band: ₹1258, Lower Price Band: ₹1195 )
What is the minimum amount required to apply for Entero Healthcare IPO?
The minimum investment for retailers to apply for Entero Healthcare IPO is ₹13,838 and the maximum investment is ₹193,732.
What is going on gray market premium of Entero Healthcare IPO?
View gray market premium of Entero Healthcare IPO by Clicking Here
How much is the GMP of Entero Healthcare IPO?
Watch Entero Healthcare IPO GMP Today: Click Here
What is the allotment date of Entero Healthcare IPO?
The allotment date of Entero Healthcare IPO is 14 February 2024.
How to check allotment status in Entero Healthcare IPO?
To check the allotment status of Entero Healthcare IPO, first of all go to the registrar website by clicking here, select your bad Entero Healthcare IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )
What is the listing date of Entero Healthcare IPO?
The listing date of Entero Healthcare IPO is 16 February 2024.
How much will be the listing gain in Entero Healthcare IPO?
View listing gain of Entero Healthcare IPO by Clicking Here
How much time Entero Healthcare IPO is subscribed?
Total 1.53 times subscribed in Entero Healthcare IPO out of which 1.33 times subscription was done in retail quota, 0.22 times subscription in NII quota and 2.28 times subscription in QIB quota.
How to apply for Entero Healthcare IPO from Upstox?
Click Here to see how to apply for Entero Healthcare IPO from Upstox. (step by step)
How to apply for Entero Healthcare PO from Zerodha?
Click Here to see how to apply for Entero Healthcare IPO from Zerodha. (step by step)
How to apply for Entero Healthcare IPO from Angle One?
Click Here to see how to apply for Entero Healthcare IPO from Angle One. (step by step)